AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionQuadrant Capital Group Llc
Latest Disclosed Ownership56,226 shares
Latest Disclosed Value $ 12,228,552
Quadrant Capital Group Llc reports 4.34% increase in ownership of 4AB / AbbVie Inc.

On May 13, 2026 - Quadrant Capital Group Llc filed a 13F-HR/A form disclosing ownership of 56,226 shares of AbbVie Inc. (BG:4AB) valued at $12,228,552 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 53,887 shares of AbbVie Inc.. This represents a change in shares of 4.34% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 ABBVIE COM 00287Y109 56,226 2,339 4.34 12,229 -0.68 0.3656
2026-05-11 2026-03-31 13F ABBVIE COM 00287Y109 56,226 2,339 49 0.0369
2026-02-12 2025-12-31 13F ABBVIE COM 00287Y109 53,887 -460 -0.85 12,313 -2.15 0.3720
2025-11-13 2025-09-30 13F ABBVIE COM 00287Y109 54,347 1,639 3.11 12,583 28.62 0.4091
2025-08-13 2025-06-30 13F ABBVIE COM 00287Y109 52,708 -522 -0.98 9,784 -12.28 0.3521
2025-05-13 2025-03-31 13F ABBVIE COM 00287Y109 53,230 18,701 54.16 11,153 81.78 0.4142
2025-02-13 2024-12-31 13F ABBVIE COM 00287Y109 34,529 -584 -1.66 6,136 -11.52 0.4224
2024-11-12 2024-09-30 13F ABBVIE COM 00287Y109 35,113 -251 -0.71 6,934 14.33 0.4817
2024-08-12 2024-06-30 13F ABBVIE COM 00287Y109 35,364 823 2.38 6,066 -3.56 0.4504
2024-05-15 2024-03-31 13F ABBVIE COM 00287Y109 34,541 1,233 3.70 6,290 21.86 0.4967
2024-02-08 2023-12-31 13F ABBVIE COM 00287Y109 33,308 3,537 11.88 5,162 16.32 0.4434
2023-11-14 2023-09-30 13F ABBVIE COM 00287Y109 29,771 1,892 6.79 4,438 18.13 0.4443
2023-08-10 2023-06-30 13F ABBVIE COM 00287Y109 27,879 -856 -2.98 3,756 -17.97 0.3727
2023-05-11 2023-03-31 13F ABBVIE COM 00287Y109 28,735 1,811 6.73 4,580 5.24 0.4768
2023-02-13 2022-12-31 13F ABBVIE COM 00287Y109 26,924 2,047 8.23 4,351 30.31 0.4931
2022-11-10 2022-09-30 13F ABBVIE COM 00287Y109 24,877 2,733 12.34 3,339 -1.56 0.4415
2022-08-09 2022-06-30 13F ABBVIE COM 00287Y109 22,144 -66 -0.30 3,392 -5.80 0.4557
2022-05-06 2022-03-31 13F ABBVIE COM 00287Y109 22,210 935 4.39 3,601 24.99 0.4360
2022-02-01 2021-12-31 13F ABBVIE COM 00287Y109 21,275 6,986 48.89 2,881 86.96 0.3438
2021-11-12 2021-09-30 13F ABBVIE COM 00287Y109 14,289 171 1.21 1,541 -3.08 0.2150
2021-08-09 2021-06-30 13F ABBVIE COM 00287Y109 14,118 460 3.37 1,590 7.58 0.2306
2021-05-12 2021-03-31 13F ABBVIE COM 00287Y109 13,658 599 4.59 1,478 5.65 0.2399
2021-02-16 2020-12-31 13F ABBVIE COM 00287Y109 13,059 -37 -0.28 1,399 21.97 0.2598
2020-11-13 2020-09-30 13F ABBVIE COM 00287Y109 13,096 -1,938 -12.89 1,147 -22.29 0.2500
2020-08-13 2020-06-30 13F ABBVIE COM 00287Y109 15,034 -3,590 -19.28 1,476 4.46 0.3267
2020-05-15 2020-03-31 13F Abbvie Com 00287Y109 18,624 609 3.38 1,413 -9.07 0.2365
2020-03-19 2019-12-31 13F/A-1 Abbvie Com 00287Y109 18,015 2,749 18.01 1,554 36.68 0.1874
2020-02-03 2019-12-31 13F Abbvie Com 00287Y109 18,015 2,749 1,554 5,251.1687
2019-10-24 2019-09-30 13F Abbvie COM 00287Y109 15,266 1,349 9.69 1,137 14.85 0.1749
2019-07-24 2019-06-30 13F Abbvie COM 00287Y109 13,917 844 6.46 990 -4.16 0.1567
2019-04-29 2019-03-31 13F Abbvie COM 00287Y109 13,073 2,793 27.17 1,033 11.31 0.1815
2019-01-17 2018-12-31 13F ABBVIE COM 00287Y109 10,280 -982 -8.72 928 -11.03 0.2473
2018-10-29 2018-09-30 13F ABBVIE COM 00287Y109 11,262 -92 -0.81 1,043 1.46 0.2980
2018-08-08 2018-06-30 13F ABBVIE COM 00287Y109 11,354 74 0.66 1,028 -1.81 0.3604
2018-05-10 2018-03-31 13F ABBVIE COM 00287Y109 11,280 92 0.82 1,047 -1.69 0.3797
2018-01-31 2017-12-31 13F ABBVIE COM 00287Y109 11,188 58 0.52 1,065 9.79 0.4246
2017-10-13 2017-09-30 13F AbbVie COM 00287Y109 11,130 24 0.22 970 33.61 0.4002
2017-08-14 2017-06-30 13F AbbVie COM 00287Y109 11,106 1,051 10.45 726 12.91 0.3209
2017-04-10 2017-03-31 13F AbbVie COM 00287Y109 10,055 462 4.82 643 9.17 0.2826
2017-01-11 2016-12-31 13F AbbVie COM 00287Y109 9,593 219 2.34 589 1.55 0.2954
2016-10-25 2016-09-30 13F AbbVie COM 00287Y109 9,374 40 0.43 580 2.47 0.3784
2016-07-28 2016-06-30 13F AbbVie COM 00287Y109 9,334 36 0.39 566 8.22 0.3893
2016-04-27 2016-03-31 13F AbbVie COM 00287Y109 9,298 675 7.83 523 3.98 0.3389
2016-01-28 2015-12-31 13F AbbVie COM 00287Y109 8,623 -623 -6.74 503 1.21 0.3481
2015-10-28 2015-09-30 13F AbbVie COM 00287Y109 9,246 -708 -7.11 497 -25.26 0.3429
2015-08-12 2015-06-30 13F AbbVie COM 00287Y109 9,954 9,954 665 0.4232
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.